Veracyte Revenue, Growth & Competitor Profile

DBA VERACYTE INC

Company Profile & Annual Report for Veracyte

Access the complete profile.

Veracyte Fast Facts

Revenue	$100 - $500 million    See Exact Annual Revenue
Employees	100 - 500Exact Company Size
Primary Industry	621511 Medical Laboratories
Address	6000 Shoreline Ct Ste 300 South San Francisco, CA 94080

Note: Revenues for privately held companies are statistical evaluations.


Veracyte's Annual Report & Profile shows critical firmographic facts:

• What is the company's size? (Annual sales and employees)
  • Veracyte's annual revenues are $100 - $500 million (see exact revenue data)
• What industry is the company in?
  • Veracyte is classified as operating in the Medical Laboratories industry, NAICS Code 621511.

Veracyte Annual Revenue and Growth Rate

Veracyte	Revenue Est. ($ Million)	Growth Rate (%)	# Employees
2025	$100 - $500 million Details in Premium Report
2024
2023
2021
2020
2019

1-Year Growth Rate: 3-Year Growth Rate (CAGR):

Note: Veracyte's revenues are gauged from an analysis of company filings.

Veracyte's Income Statement (based on Industry Averages)

Veracyte P&L	$ Millions
Revenue (Sales)
Cost of Goods Sold
Gross Profit
Operating Expenses
Advertising
Salaries and wages
Other Operating Expenses
Total Operating Expenses
Operating Income
EBITDA
EBIT (Earnings Before Interest and Taxes)
Net Profit

Trademark Applications

Trademark applications show the products and services that Veracyte is developing and marketing. Veracyte doesn't have any recent trademark applications, indicating Veracyte is focusing on its existing business rather than expanding into new products and markets. Trademarks may include brand names, product names, logos and slogans.

Trademark	Date
MORE ABOUT YOU Printed guides regarding cancer treatments for patients and caregivers	02/18/2020
DECIPHER BIOSCIENCES Providing medical testing and reporting services for diagnostic, prognostic and predictive purposes for cancer and related diseases	05/31/2019
LYMPHMARK diagnostic reagents for medical use in the field of cancer, namely, lymphomas including diffuse large B-cell lymphoma; diagnostic reagent kits comprising primarily diagnostic reagents for medical use in the field of cancer, namely, lymphomas including diffuse large B-cell lymphoma	09/05/2017

See all trademarks and details in the Full Report.

Market Share of Veracyte's Largest Competitors

A competitive analysis shows these companies are in the same general field as Veracyte, even though they may not compete head-to-head. These are the largest companies by revenue. However, they may not have the largest market share in this industry if they have diversified into other business lines. The "Competition" section of a business plan or investment memorandum would start by analyzing the information about these companies. Competitive advantage comes from offering better pricing or superior products/service.

Company	Headquarters	Revenue ($ MM)
PHYSICIANS IMMUNODIAGNOSTIC LABORATORY	Burbank, CA	100
ACCU REFERENCE MEDICAL LAB LIMITED LIABILITY	Linden, NJ	100
CENTOGENE US	Cambridge, MA	88
LATARA ENTERPRISE	Pomona, CA	61
TELIGENT PHARMA	Vineland, NJ	46
COVID CLINIC	Huntington Beach, CA	37
VIKOR SCIENTIFIC	Charleston, SC	33
BIOTHERANOSTICS	San Diego, CA	31
SHERMAN-ABRAMS LABORATORY	Brooklyn, NY	31

Nearby Competitors

These companies are similar in business line and location to Veracyte. While some companies compete with neighboring businesses for customers, other companies may compete to attract skilled employees.

Company	Headquarters	Revenue ($ MM)
GRAIL	Menlo Park, CA	100
BILLIONTOONE	Menlo Park, CA	43
MYOVANT SCIENCES	Brisbane, CA	33
VERACYTE	South San Francisco, CA	23
AVELLINO LAB USA	Menlo Park, CA	9
VENN BIOSCIENCES	South San Francisco, CA	6

Future Competition: Veracyte's Fastest Growing Competitors

These companies are in the same general field as Veracyte and are rapidly expanding. Companies may grow organically or through acquisition. In some cases apparently high growth rates may be caused by data that weren't available in previous years.

Company	Revenue ($ MM)